NYSE : CVS
CVS Health Corporation — Key statistics
Healthcare · Healthcare Plans · United States
Last price 90.33 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 115.53B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 115.43B |
| Enterprise Value | 177.78B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Oct 22, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 90.35% |
| Float | 1.28B |
Ratios
| Measure | Value |
|---|
| PE Ratio | 23.65 |
| Forward PE | 11.11 |
| PS Ratio | 0.28 |
| Forward PS | 0.27 |
| PB Ratio | 1.45 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.82 |
| P/OCF Ratio | 7.81 |
| PEG Ratio | 0.94 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 36.35 |
| EV / Sales | 0.43 |
| EV / EBITDA | 10.66 |
| EV / EBIT | 14.62 |
| EV / FCF | 15.12 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.87 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 3.87 |
| Debt / FCF | 6.49 |
| Interest Coverage | 3.92 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 6.21% |
| Return on Assets (ROA) | 2.97% |
| Return on Invested Capital (ROIC) | 7.17% |
| Return on Capital Employed (ROCE) | 7.29% |
| Weighted Average Cost of Capital (WACC) | 5.84% |
| Revenue Per Employee | $1.38M |
| Profits Per Employee | $16,300 |
| Employee Count | 300,000 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 20.32 |
Taxes
| Measure | Value |
|---|
| Income Tax | 902.00M |
| Effective Tax Rate | 15.59% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +11.97% |
| 50-Day Moving Average | 91.23 |
| 200-Day Moving Average | 88.79 |
| Relative Strength Index (RSI) | 47.49 |
| Average Volume (20 Days) | 8,364,654 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 16.19M |
| Short Previous Month | 16.12M |
| Short % of Shares Out | 1.27% |
| Short % of Float | 1.27% |
| Short Ratio (days to cover) | 1.63 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 412.65B |
| Gross Profit | 56.31B |
| Operating Income | 12.16B |
| Pretax Income | 5.79B |
| Net Income | 4.89B |
| EBITDA | 16.68B |
| EBIT | 12.16B |
| Earnings Per Share (EPS) | $3.82 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.96B |
| Total Debt | 76.31B |
| Net Cash | -62.35B |
| Net Cash Per Share | -$48.75 |
| Equity (Book Value) | 79.90B |
| Book Value Per Share | 62.36 |
| Working Capital | -11.70B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 14.78B |
| Capital Expenditures | -3.02B |
| Depreciation & Amortization | 4.52B |
| Net Borrowing | -5.23B |
| Free Cash Flow | 11.76B |
| FCF Per Share | $9.19 |
Margins
| Measure | Value |
|---|
| Gross Margin | 13.64% |
| Operating Margin | 2.95% |
| Pretax Margin | 1.40% |
| Profit Margin | 1.19% |
| EBITDA Margin | 4.04% |
| EBIT Margin | 2.95% |
| FCF Margin | 2.85% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.66 |
| Dividend Yield | 2.95% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 69.70% |
| FCF Payout Ratio | 28.93% |
| Buyback Yield | -1.19% |
| Shareholder Yield | 1.76% |
| Earnings Yield | 4.23% |
| FCF Yield | 10.19% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $115.48 |
| Price Target Difference | 27.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 3.88% |
| EPS Growth Forecast (3Y) | 12.83% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |